product summary
Loading...
company name :
R&D Systems
product type :
ELISA/assay
product name :
Human IGFBP-2 Quantikine ELISA Kit
catalog :
DGB200
quantity :
1 Kit
price :
655 USD
more info or order :
citations: 7
Reference
Alrashid M, Al Serri A, Hussain R, Al Bustan S, Al Barrak J. Association Study of IGF-1 rs35767 and rs6214 Gene Polymorphisms with Cancer Susceptibility and Circulating Levels of IGF-1, IGFBP-2, and IGFBP-3 in Colorectal Cancer Patients. Biomedicines. 2023;11: pubmed publisher
Alicea G, Portuallo M, Patel P, Fane M, Carey A, Speicher D, et al. Age-related increases in IGFBP2 increase melanoma cell invasion and lipid synthesis. bioRxiv. 2023;: pubmed publisher
Shimizu M, Koma Y, Sakamoto H, Tsukamoto S, Kitamura Y, Urakami S, et al. Metallothionein 2A Expression in Cancer-Associated Fibroblasts and Cancer Cells Promotes Esophageal Squamous Cell Carcinoma Progression. Cancers (Basel). 2021;13: pubmed publisher
Fahlbusch P, Knebel B, H xf6 rbelt T, Barbosa D, Nikolic A, Jacob S, et al. Physiological Disturbance in Fatty Liver Energy Metabolism Converges on IGFBP2 Abundance and Regulation in Mice and Men. Int J Mol Sci. 2020;21: pubmed publisher
Sakimoto S, Marchetti V, Aguilar E, Lee K, Usui Y, Murinello S, et al. CD44 expression in endothelial colony-forming cells regulates neurovascular trophic effect. JCI Insight. 2017;2:e89906 pubmed publisher
Liu C, Bramer L, Webb Robertson B, Waugh K, Rewers M, Zhang Q. Temporal profiles of plasma proteome during childhood development. J Proteomics. 2017;152:321-328 pubmed publisher
Kiss K, Baghy K, Spisák S, Szanyi S, Tulassay Z, Zalatnai A, et al. Chronic hyperglycemia induces trans-differentiation of human pancreatic stellate cells and enhances the malignant molecular communication with human pancreatic cancer cells. PLoS ONE. 2015;10:e0128059 pubmed publisher
image
image 1 :
R&D Systems DGB200 image 1
Human IGFBP-2 ELISA Standard Curve
product information
master code :
DGB200
SKU :
DGB200
product name :
Human IGFBP-2 Quantikine ELISA Kit
unit size :
1 Kit
description :
The Human IGFBP-2 Quantikine ELISA Kit from R&D Systems is a Solid Phase Sandwich ELISA that quantifies human IGFBP-2 in cell culture supernates (50 ul), serum (10 ul), edta plasma (10 ul), heparin plasma (10 ul), urine (10 ul).
target :
IGFBP-2
category :
ELISAs
species :
Human
specificity :
Natural and recombinant human IGFBP-2
gene symbol :
IGFBP2
kit type :
Solid Phase Sandwich ELISA
assay length :
3.5 hours
elisaSampleTypes :
Cell Culture Supernates (50 uL), Serum (10 uL), EDTA Plasma (10 uL), Heparin Plasma (10 uL), Urine (10 uL)
elisaSensitivity :
0.09 ng/mL
elisaRange :
0.31 - 20 ng/mL
top caption :
Human IGFBP-2 ELISA Standard Curve
applications :
ELISA
USD :
655 USD
product details :
The Quantikine Human IGFBP-2 Immunoassay is a 3.5 hour solid-phase ELISA designed to measure human IGFBP-2 in cell culture supernates, serum, plasma, and urine. It contains NS0-expressed recombinant human IGFBP-2 and has been shown to accurately quantitate the recombinant factor. Results obtained using natural human IGFBP-2 showed linear curves that were parallel to the standard curves obtained using the Quantikine kit standards. These results indicate that this kit can be used to determine relative mass values for naturally occurring human IGFBP-2.
alt names :
BP2, IBP2, IBP-2, IGF-binding protein 2, IGFBP2, IGFBP-2, IGF-BP53, insulin-like growth factor binding protein 2 (36kD), insulin-like growth factor binding protein 2, 36kDa, insulin-like growth factor-binding protein 2
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.